Policies and Programs for Cervical Cancer Prevention and Control in Public Health Services An Integrative Review

Main Article Content

Sara Gallert Sperling
Janaína Coser

Abstract

Abstract


Aim: analyzing and assessing the scientific evidences about Health Services Administration through the practice of cervical cancer prevention programs and policies. Methodology: integrative literature review carried out in September/October 2017. Electronic search for publications in databases such as PubMed, Portal Periódicos CAPES, BVS, EBSCO and SciELO. Results and Discussion: eighteen articles approaching the topic were selected and their analyses resulted in the following thematic axes: Organization of cervical cancer prevention and control policies/programs, Follow-up and monitoring of actions taken and Quality Management of Cytopathological exams for diagnostic and treatment. There were differences between programs in the country, either in their recommendations or in their effectiveness. Final considerations: investments must be done in order to qualify technical procedures and involved health professionals, as well as to support health education in the target population.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sperling, S., & Coser, J. (2018). Policies and Programs for Cervical Cancer Prevention and Control in Public Health Services. International Journal for Innovation Education and Research, 6(6), 07-20. https://doi.org/10.31686/ijier.Vol6.Iss6.1034
Section
Articles
Author Biographies

Sara Gallert Sperling

Programa de Pós Graduação Stricto Sensu em Atenção Integral à Saúde (UNICRUZ/UNIJUÍ)

Janaína Coser, Universidade de Cruz Alta - UNICRUZ

Biomedical. PhD in Cell and Molecular Biology Applied to Health. Professor at the Medical School (UNICRUZ) and at PPGAIS (UNIJUI/UNICRUZ).

References

6. References
[1] INCA - Câncer - Tipo - Colo do Útero [Internet]. Www2.inca.gov.br. 2018 [cited 9 March 2018]. Available from: http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/colo_utero/definicao.
[2] Brasil. Controle dos cânceres do colo do útero e da mama. 2. ed. Brasília: Editora do Ministério da Saúde; 2013. 124 p.
[3] European Union. European guidelines for quality assurance in cervical cancer screening: Supplements. 2nd. ed. European Union: Health; 2015. 194 p.
[4] American Cancer Society. The American Cancer Society Guidelines for the Prevention and Early Detection of Cervical Cancer [online]. 2018. [Cited 2018 Mar 08]. Available from: URL: https://www.cancer.org/cancer/cervical-cancer/prevention-and-early-detection/cervical-cancer-screening-guidelines.html.
[5] Guido, R. Cervical Cancer Screening. Clinical Obstetrics and Gynecology 2018 Mar; 61 (1): 40-51.
[6] Brasil. Diretrizes brasileiras para o rastreamento do câncer do colo do útero. 2nd ed. Rio de Janeiro: INCA; 2016. 114p.
[7] Elfstrom, K. M. et al. Cervical cancer screening in Europe: Quality assurance and organisation of programmes. European Journal of Cancer, 2015; 51: 950-968.
[8] IARC. Fact Sheets by Population [Internet]. Globocan.iarc.fr. 2018 [cited 9 March 2018]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
[9] Tanaka OY, Tamaki EM. O papel da avaliação para a tomada de decisão na gestão de serviços de saúde. Rev. Ciência e Saúde Coletiva, 2012; 17 (4): 821-828.
[10] Ercole FF, Melo LS, Alcoforado CLGC. Revisão Integrativa versus Revisão Sistemática. Rev. Min. Enferm, 2014 jan/mar; 18 (1): 9-11.
[11] Mendes KDS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm, 2008 Oct/Dez; 17 (4): 758-64.
[12] Botelho LLR, Cunha CCA, Macedo M. O método da revisão integrativa nos estudos organizacionais. Revista eletrônica gestão e sociedade, 2011 may/aug; 5 (11): 121-136.
[13] Bottari CMS, Vasconcellos MM, Mendonça MHM. Câncer cérvico-uterino como condição marcadora: uma proposta de avaliação da atenção básica. Cad. Saúde Pública. 2008; 24 Suppl 1: 111-122.
[14] Castanheira ERL, Nemes MIB, Zarili TFT, Sanine PR, Corrente JE. Avaliação de serviços de Atenção Básica em municípios de pequeno e médio porte no estado de São Paulo: resultados da primeira aplicação do instrumento QualiAB. Saúde em Debate, 2014 Oct-Dez; 38 (103): 679-691.
[15] Ohira RHF, Junior LC, Nunes EFPA. Análise das práticas gerenciais na Atenção Primária à Saúde nos municípios de pequeno porte do norte do Paraná, Brasil. Ciência & Saúde Coletiva, 2014; 19 (11): 4439-4448.
[16] Barcelos MRB, Lima RCD, Tomasi E, Nunes BP, Duro SMS, Facchini LA. Qualidade do rastreamento do câncer de colo uterino no Brasil: avaliação externa do PMAQ. Rev Saude Publica. 2017 July 20; 51:1-13.
[17] Brito-Silva K, Bezerra AFB, Chaves LDP, Tanaka OY. Integralidade no cuidado ao câncer do colo do útero: avaliação do acesso. Revista de Saúde Pública, 2014; 48(2): 240-248.
[18] Uchimura NS, Nakano K, Nakano LCG, Uchimura TT. Qualidade e desempenho das colpocitologias na prevenção de câncer de colo uterino. Rev. Assoc. Med. Bras. 2009; 55 (5): 569-574.
[19] DeGroff A, Royalty JE, Howe W, Buckman DW, Gardner J, Poister T, et al. When performance management works: A study of the National Breast and Cervical Cancer Early Detection Program. Cancer, 2014 Aug 15; 120 (16): 2566-2574.
[20] Miles-Richardson S, Blumenthal D, Alema-Mensah E. A Comparison of Breast and Cervical Cancer Legislation and Screening in Georgia, North Carolina, and South Carolina. Journal Of Health Care For The Poor And Underserved, 2012 May; 23 (2): 98-108.
[21] Sabatino SA, White MC, Thompson TD, Klabunde CN. Cancer Screening Test Use — United States, 2013. Morbidity and Mortality Weekly Report, 2015 May 08; 64 (17): 464-468.
[22] White A, Thompson TD, White MC, Sabatino SA, Moor J, Doria-rose PV, et al. Cancer Screening Test Use — United States, 2015. Morbidity and Mortality Weekly Report, 2017 Mar 03; 66(8): 201-206.
[23] Arrossi S, Paolino M, Sankaranarayanan R. Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina. Rev Panam Salud Publica. 2010; 28(4): 249–57.
[24] Olesen SC, Butterworth P, Jacomb P, Tait R.J. Personal factors influence use of cervical cancer screening services: epidemiological survey and linked administrative data address the limitations of previous research. Bmc Health Services Research, 2012 Feb; 12 (1): 1-9.
[25] Maar M. et al. A Qualitative Study of Provider Perspectives of Structural Barriers to Cervical Cancer Screening Among First Nations Women. Women's Health Issues, 2013 Sep; 23(5): 319–325.
[26] Herbert A, Holdsworth G, Kubba AA. Cervical screening: why young women should be encouraged to be screened. J Fam Plann Reprod Health Care, 2008; 34 (1): 21-25.
[27] Ronco G, Giubilato P, Naldoni C, Zorzi M, Anguinoni E, Scalisi A, et al. Extension of organised cervical cancer screening programmes in Italy and their process indicators. Epidemiol Prev, 2007 Mar/Jun; 31 Suppl 2 (2-3): 33-47.
[28] Maseko F, Chirwa M, Muula A. Cervical cancer control and prevention in Malawi: need for policy improvement. Pan African Medical Journal. 2015; 22: 1-5.
[29] Parham GP. et al. Population-Level Scale-Up of Cervical Cancer Prevention Services in a Low-Resource Setting: Development, Implementation, and Evaluation of the Cervical Cancer Prevention Program in Zambia. Plos One, [s.l.], 2015 Apr 17; 10 (4): 1-19.
[30] Canfell K, Barnabas R, Patnick J, Beral V. The predicted effect of changes in cervical screening practice in the UK: results from a modelling study. British Journal Of Cancer, [S.l.], 2004 July 13; 91 (3): 530-536.
[31] CDC - National Breast and Cervical Cancer Early Detection Program (NBCCEDP) [Internet]. Cdc.gov. 2018 [cited 25 May 2018]. Available from: https://www.cdc.gov/cancer/nbccedp/index.htm.
[32] Healthy People 2020 [Internet]. Office of Disease Prevention and Health Promotion. Healthypeople.gov. 2018 [cited 25 May 2018]. Available from: https://www.healthypeople.gov/.
[33] Costa, Júlio Pinto da. A reforma Obama e o sistema de saúde dos EUA. Arquivos de Medicina. 2013; 27(4): 158-167.
[34] Canadian Task Force on Preventive Health Care [Internet]. Canadian task force.ca. 2018 [cited 10 Apr 2018]. Available from: https://canadiantaskforce.ca/.
[35] National cancer control programmes: policies and managerial guidelines. 2nd ed. Geneva: World Health Organization; 2002.
[36] OMS: 85% das mortes por câncer de colo de útero ocorrem em países de média e baixa renda [Internet]. ONU. 2017 [cited 10 Apr 2018]. Available from: https://nacoesunidas.org/oms-85-das-mortes-por-cancer-de-colo-de-utero-ocorrem-em-paises-de-media-e-baixa-renda/>.
[37] Gomez A. Cervical Cancer | PAHO WHO [Internet]. Pan American Health Organization / World Health Organization. 2018 [cited 10 Apr 2018]. Available from: http://www.paho.org/hq/index.php?option=com_content&view=article&id=5420&Itemid=3637&lang=pt.
[38] Vieira-da-Silva LM. Avaliação de políticas e programas de saúde. Rio de Janeiro: Scielo Editora FIOCRUZ; 2014.
[39] Teixeira M, Casanova A, Oliveira C, Engstrom E, Bodstein R. Avaliação das práticas de promoção da saúde: um olhar das equipes participantes do Programa de Melhoria do Acesso e Qualidade da Atenção Básica – PMAQ-AB. Saúde em Debate, 2014 Out; 38(special): 52-68.
[40] Liebermann E, VanDevanter N, Hammer M, Fu M. Social and Cultural Barriers to Women’s Participation in Pap Smear Screening Programs in Low- and Middle-Income Latin American and Caribbean Countries: An Integrative Review. Journal of Transcultural Nursing. 2018:1-12.
[41] Jin X, Lipold L, McKenzie M, Sikon A. Cervical cancer screening: What's new and what's coming?. Cleveland Clinic Journal of Medicine. 2013; 80(3): 153-160.
[42] Vaccarella S, Laversanne M, Ferlay J, Bray F. Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends. International Journal Of Cancer, [s.l.], 2017 Aug 10; 141 (10): 1997-2001.
[43] Costa R, Longatto-Filho A, de Lima Vazquez F, Pinheiro C, Zeferino L, Fregnani J. Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013. BMC Cancer. 2018; 18(1).
[44] Ribeiro C, Silva G. Avaliação da produção de procedimentos da linha de cuidado do câncer do colo do útero no Sistema Único de Saúde do Brasil em 2015*. Epidemiologia e Serviços de Saúde. 2018;27(1): 1-10.
[45] Antilla A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. Cervical cancer screening policies and coverage in Europe. European Journal Of Cancer. 2009 Oct; 45 (15): 2649-58.

Most read articles by the same author(s)